![Activatory and Inhibitory Fcγ Receptors Augment Rituximab-mediated Internalization of CD20 Independent of Signaling via the Cytoplasmic Domain* - Journal of Biological Chemistry Activatory and Inhibitory Fcγ Receptors Augment Rituximab-mediated Internalization of CD20 Independent of Signaling via the Cytoplasmic Domain* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/8ab21f7a-7b78-44ee-a56e-45f597610977/gr1.jpg)
Activatory and Inhibitory Fcγ Receptors Augment Rituximab-mediated Internalization of CD20 Independent of Signaling via the Cytoplasmic Domain* - Journal of Biological Chemistry
![Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX) treatment history as well as relapse history for 100 days prior to the first RTX. - ppt download Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX) treatment history as well as relapse history for 100 days prior to the first RTX. - ppt download](https://slideplayer.com/16987602/98/images/slide_1.jpg)
Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX) treatment history as well as relapse history for 100 days prior to the first RTX. - ppt download
![Del(17p) influences the pharmacokinetics of rituximab (RTX). Del(17p)... | Download Scientific Diagram Del(17p) influences the pharmacokinetics of rituximab (RTX). Del(17p)... | Download Scientific Diagram](https://www.researchgate.net/publication/330720431/figure/fig1/AS:720582769405953@1548811728343/Del17p-influences-the-pharmacokinetics-of-rituximab-RTX-Del17p-CLL-patients-have-a.png)
Del(17p) influences the pharmacokinetics of rituximab (RTX). Del(17p)... | Download Scientific Diagram
![In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram](https://www.researchgate.net/publication/349166570/figure/fig4/AS:995501566590977@1614357477657/In-vitro-and-in-vivo-treatment-with-rituximab-RTX-leads-to-CD20KO-phenotype-A-Flow.png)
In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram
![Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram](https://www.researchgate.net/profile/Michael-Centola/publication/8471126/figure/fig1/AS:267721455697958@1440841177264/Percentage-of-apoptosis-in-untreated-versus-rituximab-RTX-treated-peripheral-blood-B.png)
Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram
![Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome | The Journal of Rheumatology Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/47/6/896/F2.large.jpg)
Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome | The Journal of Rheumatology
![Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology](https://kidney360.asnjournals.org/content/kidney360/1/5/359/F1.large.jpg)
Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology
![Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis - ScienceDirect Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165572819300645-ga1.jpg)
Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis - ScienceDirect
![Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies | Inflammation and Regeneration | Full Text Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies | Inflammation and Regeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41232-018-0079-4/MediaObjects/41232_2018_79_Fig2_HTML.png)
Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies | Inflammation and Regeneration | Full Text
![Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura - The Journal of Pediatrics Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura - The Journal of Pediatrics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/94c6329d-1482-4a08-8383-4ace3dbf0428/gr1_lrg.jpg)
Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura - The Journal of Pediatrics
![Rituximab-Monotherapie im Vergleich zur Kombination von RTX mit Methotrexat oder Leflunomid – eine deutsche Studie zur Therapie der aktiven RA mit RTX in der täglichen Routine – rheuma-online Rituximab-Monotherapie im Vergleich zur Kombination von RTX mit Methotrexat oder Leflunomid – eine deutsche Studie zur Therapie der aktiven RA mit RTX in der täglichen Routine – rheuma-online](https://www.rheuma-online.de/uploads/pics/RTX-Kombi.jpg)
Rituximab-Monotherapie im Vergleich zur Kombination von RTX mit Methotrexat oder Leflunomid – eine deutsche Studie zur Therapie der aktiven RA mit RTX in der täglichen Routine – rheuma-online
![Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig3_HTML.png)
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
![specificity for rituximab (rtx) and infliximab (ifx) peptides of the... | Download Scientific Diagram specificity for rituximab (rtx) and infliximab (ifx) peptides of the... | Download Scientific Diagram](https://www.researchgate.net/publication/316742582/figure/fig2/AS:614280093265920@1523467195003/specificity-for-rituximab-rtx-and-infliximab-ifx-peptides-of-the-cD4-T-cells.png)
specificity for rituximab (rtx) and infliximab (ifx) peptides of the... | Download Scientific Diagram
![Increase in the density of CD20 improves the efficacy of rituximab (... | Download Scientific Diagram Increase in the density of CD20 improves the efficacy of rituximab (... | Download Scientific Diagram](https://www.researchgate.net/profile/Yves-Renaudineau/publication/23259859/figure/fig2/AS:310568687816706@1451056753294/Increase-in-the-density-of-CD20-improves-the-efficacy-of-rituximab-RTX-A-left.png)
Increase in the density of CD20 improves the efficacy of rituximab (... | Download Scientific Diagram
טוויטר \ ERA - European Renal Association בטוויטר: "Pierre Ronco. Rituximab in membranous nephropathy. MENTOR-trial. Rtx is as effective as Cs in inducing C/PR #ERAEDTA18 #RITUXIMAB #RtxGlomerulardisease https://t.co/Ein148uebM"
![Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram](https://www.researchgate.net/profile/Yves-Renaudineau/publication/326842632/figure/fig4/AS:656719470395392@1533585531602/Hypersialylation-characterizes-CLL-cells-resistant-to-rituximab-RTX-induced.png)
Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram
![Level of rituximab (RTX) and B cells after initiation of RTX therapy in... | Download Scientific Diagram Level of rituximab (RTX) and B cells after initiation of RTX therapy in... | Download Scientific Diagram](https://www.researchgate.net/profile/Jasper-Stevens/publication/278047551/figure/fig1/AS:294318574194698@1447182424399/Level-of-rituximab-RTX-and-B-cells-after-initiation-of-RTX-therapy-in-nephrotic.png)
Level of rituximab (RTX) and B cells after initiation of RTX therapy in... | Download Scientific Diagram
![A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2004293341/2017814654/gr3.jpg)